Global Regenerative Therapies Market: 2019-2027

The global regenerative therapies market is expected to register a CAGR of xx % during the forecast period (2020 - 2027) Regenerative therapy is an emerging field of medical science, recent development in biotechnology to improve healing by using the body’s mechanisms. Regenerative Therapies are used in specific applications such as cells or cell products for diseased tissues or organs restoration process. The regenerative therapies are used in laboratories and medical facilities to grow tissues and organs, which can be implanted in the body. Major medical conditions like heart failure, insulin-dependent diabetics, spinal cord injury, and Alzheimer's diseases are advised to address using cell-based therapies. While some setbacks have unfortunately marked the groundbreaking stage leading to regenerative therapies market growth, thanks to sound commercial products for skin ulcers and sports injury damage to the cartilage of the knee are now available in the market. Treatment of patients with bladder dysfunction is also possible using regenerative therapies. These therapies use either autologous or allogeneic somatic cells, and the drugs have a biomaterial aspect in the case of the skin and bladder. The report covers the detailed analysis global regenerative therapies with the classifications of the market on the product type, applications, and region. Analysis of past market dynamics from 2016 to 2019 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players' contribution in it. The report has profiled major key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. The manufacturing environment in each region is different and focus is given on the regional impact on the cost of manufacturing, supply chain, availability of raw materials, labor cost, availability of advanced technology, trusted vendors are analyzed and the report has come up with recommendations for a future hot spot in APAC region. The major country’s policies about the oil and gas industry and its impact on therapies service providers are covered in the report.

global regenerative therapies market Dynamics:

The pandemic of chronic diseases, compounded by the scarcity of usable donor organs, are driving the regenerative therapies market growth. In treating degenerative diseases, regenerative therapies offer innovative solutions. The evolving regenerative armamentarium aims to increase the aptitude of human tissues for self-renewal by exploiting newfound awareness of the intimate processes central to organogenesis and healing. The increasing number of diabetes patients and obesity patient count boosts the demand for regenerative therapies. In the US, the development of regenerative therapies and medicines under the 21st-century cures act is expected to create an enormous market opportunity for the market players in the nearer future. The US the health department and the government are actively funding research and development of new medicines to fight cancer and heart problems. Global Regenerative Therapies Market To know about the Research Methodology :- Request Free Sample Report Tissue Engineered Products holds a major market share in 2019 and is expected to grow at a CAGR of xx% during the forecast period The tissue-engineered products are expected to grow at the highest CAGR during the forecast period. Tissue-engineered products are produced from living cells or tissues, with the final product containing feasible or non-feasible cells. Increasing development of medical science and clinical research is expected to grow the application of tissue-engineered products. The Progenitor & Stem Cell Therapies segment is expected to reach US$ XX Mn by 2027. Other segments are covered in the report with the application, drivers, regional market size, share, and condition.

global regenerative therapies market Regional Insights

Global Regenerative Therapies Market1 The Asia Pacific commands the Regenerative Therapies market, with a share of xx% in 2019. The Asia Pacific is leading the Regenerative Therapies market, Thanks to the medical sector growth and increasing contract research outsourcing in countries like China, India, Japan, South Korea, and others. Recently the medical facilities in the Asia Pacific have grown by xx% than the previous year 2018. Highly-skilled local talent and increasing government funding is expected to drive the market during the forecast period. Followed by North America, the countries in North America, such as the US and Canada are increasingly funding the regenerative therapies development, which is driving the market in the region. The objective of the report is to present a comprehensive analysis of the Global Regenerative Therapies Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Regenerative Therapies Market dynamics, structure by analyzing the market segments and project the Global Regenerative Therapies Market size. Clear representation of competitive analysis of key players By Product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Regenerative Therapies Market make the report investor’s guide.

Scope of the Global Regenerative Therapies Market: Inquire before buying

Global Regenerative Therapies Market, By Product

• Tissue-engineered Products • Cell Therapies • Gene Therapies • Progenitor & Stem Cell Therapies

Global Regenerative Therapies Market, By Application

• Musculoskeletal • Oncology • Wound Care • Dental • Ocular • Other Applications

Global Regenerative Therapies Market, by Region

• Asia Pacific • North America • Europe • South America • Middle East & Africa

Key players operating in Global Regenerative Therapies Market

• Acelity L.P. Inc. • Mesoblast Ltd. • Nuo Therapeutics, Inc. (Cytomedix). • Astellas Pharma US, Inc. • Organovo Holdings Inc. • Orgenesis Inc. • Sanofi. • Athersys, Inc. • Shire Pharmaceuticals Limited. • Cytori Therapeutics Inc. • Others
Global Regenerative Therapies Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Regenerative Therapies Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Regenerative Therapies Market Analysis and Forecast 6.1. Regenerative Therapies Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Regenerative Therapies Market Analysis and Forecast, By Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Regenerative Therapies Market Value Share Analysis, By Application 7.4. Global Regenerative Therapies Market Size (US$ Mn) Forecast, By Application 7.5. Global Regenerative Therapies Market Analysis, By Application 7.6. Global Regenerative Therapies Market Attractiveness Analysis, By Application 8. Global Regenerative Therapies Market Analysis and Forecast, By Product 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Regenerative Therapies Market Value Share Analysis, By Brake Used 8.4. Global Regenerative Therapies Market Size (US$ Mn) Forecast, By Brake Used 8.5. Global Regenerative Therapies Market Analysis, By Brake Used 8.6. Global Regenerative Therapies Market Attractiveness Analysis, By Brake Used 9. Global Regenerative Therapies Market Analysis, by Region 9.1. Global Regenerative Therapies Market Value Share Analysis, by Region 9.2. Global Regenerative Therapies Market Size (US$ Mn) Forecast, by Region 9.3. Global Regenerative Therapies Market Attractiveness Analysis, by Region 10. North America Regenerative Therapies Market Analysis 10.1. Key Findings 10.2. North America Regenerative Therapies Market Overview 10.3. North America Regenerative Therapies Market Value Share Analysis, By Application 10.4. North America Regenerative Therapies Market Forecast, By Application 10.4.1. Musculoskeletal 10.4.2. Oncology 10.4.3. Wound Care 10.4.4. Dental 10.4.5. Ocular 10.4.6. Other Applications 10.5. North America Regenerative Therapies Market Value Share Analysis, By Product 10.6. North America Regenerative Therapies Market Forecast, By Product 10.6.1. Tissue-engineered Products 10.6.2. Cell Therapies 10.6.3. Gene Therapies 10.6.4. Progenitor & Stem Cell Therapies 10.7. North America Regenerative Therapies Market Value Share Analysis, by Country 10.8. North America Regenerative Therapies Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America Regenerative Therapies Market Analysis, by Country 10.10. U.S. Regenerative Therapies Market Forecast, By Application 10.10.1. Musculoskeletal 10.10.2. Oncology 10.10.3. Wound Care 10.10.4. Dental 10.10.5. Ocular 10.10.6. Other Applications 10.11. U.S. Regenerative Therapies Market Forecast, By Product 10.11.1. Tissue-engineered Products 10.11.2. Cell Therapies 10.11.3. Gene Therapies 10.11.4. Progenitor & Stem Cell Therapies 10.12. Canada Regenerative Therapies Market Forecast, By Application 10.12.1. Musculoskeletal 10.12.2. Oncology 10.12.3. Wound Care 10.12.4. Dental 10.12.5. Ocular 10.12.6. Other Applications 10.13. Canada Regenerative Therapies Market Forecast, By Product 10.13.1. Tissue-engineered Products 10.13.2. Cell Therapies 10.13.3. Gene Therapies 10.13.4. Progenitor & Stem Cell Therapies 10.14. Mexico Regenerative Therapies Market Forecast, By Application 10.14.1. Musculoskeletal 10.14.2. Oncology 10.14.3. Wound Care 10.14.4. Dental 10.14.5. Ocular 10.14.6. Other Applications 10.15. Mexico Regenerative Therapies Market Forecast, By Product 10.15.1. Tissue-engineered Products 10.15.2. Cell Therapies 10.15.3. Gene Therapies 10.15.4. Progenitor & Stem Cell Therapies 10.16. North America Regenerative Therapies Market Attractiveness Analysis 10.16.1. By Application 10.16.2. By Product 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe Regenerative Therapies Market Analysis 11.1. Key Findings 11.2. Europe Regenerative Therapies Market Overview 11.3. Europe Regenerative Therapies Market Value Share Analysis, By Application 11.4. Europe Regenerative Therapies Market Forecast, By Application 11.4.1. Musculoskeletal 11.4.2. Oncology 11.4.3. Wound Care 11.4.4. Dental 11.4.5. Ocular 11.4.6. Other Applications 11.5. Europe Regenerative Therapies Market Forecast, By Product 11.5.1. Tissue-engineered Products 11.5.2. Cell Therapies 11.5.3. Gene Therapies 11.5.4. Progenitor & Stem Cell Therapies 11.6. Europe Regenerative Therapies Market Value Share Analysis, by Country 11.7. Europe Regenerative Therapies Market Forecast, by Country 11.7.1. Germany 11.7.2. U.K. 11.7.3. France 11.7.4. Italy 11.7.5. Spain 11.7.6. Sweden 11.7.7. CIS countries 11.7.8. Rest of Europe 11.8. Germany Regenerative Therapies Market Forecast, By Application 11.8.1. Musculoskeletal 11.8.2. Oncology 11.8.3. Wound Care 11.8.4. Dental 11.8.5. Ocular 11.8.6. Other Applications 11.9. Germany Regenerative Therapies Market Forecast, By Product 11.9.1. Tissue-engineered Products 11.9.2. Cell Therapies 11.9.3. Gene Therapies 11.9.4. Progenitor & Stem Cell Therapies 11.10. U.K. Regenerative Therapies Market Forecast, By Application 11.10.1. Musculoskeletal 11.10.2. Oncology 11.10.3. Wound Care 11.10.4. Dental 11.10.5. Ocular 11.10.6. Other Applications 11.11. U.K. Regenerative Therapies Market Forecast, By Product 11.11.1. Tissue-engineered Products 11.11.2. Cell Therapies 11.11.3. Gene Therapies 11.11.4. Progenitor & Stem Cell Therapies 11.12. France Regenerative Therapies Market Forecast, By Application 11.12.1. Musculoskeletal 11.12.2. Oncology 11.12.3. Wound Care 11.12.4. Dental 11.12.5. Ocular 11.12.6. Other Applications 11.13. France Regenerative Therapies Market Forecast, By Product 11.13.1. Tissue-engineered Products 11.13.2. Cell Therapies 11.13.3. Gene Therapies 11.13.4. Progenitor & Stem Cell Therapies 11.14. Italy Regenerative Therapies Market Forecast, By Application 11.14.1. Musculoskeletal 11.14.2. Oncology 11.14.3. Wound Care 11.14.4. Dental 11.14.5. Ocular 11.14.6. Other Applications 11.15. Italy Regenerative Therapies Market Forecast, By Product 11.15.1. Tissue-engineered Products 11.15.2. Cell Therapies 11.15.3. Gene Therapies 11.15.4. Progenitor & Stem Cell Therapies 11.16. Spain Regenerative Therapies Market Forecast, By Application 11.16.1. Musculoskeletal 11.16.2. Oncology 11.16.3. Wound Care 11.16.4. Dental 11.16.5. Ocular 11.16.6. Other Applications 11.17. Spain Regenerative Therapies Market Forecast, By Product 11.17.1. Tissue-engineered Products 11.17.2. Cell Therapies 11.17.3. Gene Therapies 11.17.4. Progenitor & Stem Cell Therapies 11.18. Sweden Regenerative Therapies Market Forecast, By Application 11.18.1. Musculoskeletal 11.18.2. Oncology 11.18.3. Wound Care 11.18.4. Dental 11.18.5. Ocular 11.18.6. Other Applications 11.19. Sweden Regenerative Therapies Market Forecast, By Product 11.19.1. Tissue-engineered Products 11.19.2. Cell Therapies 11.19.3. Gene Therapies 11.19.4. Progenitor & Stem Cell Therapies 11.20. CIS countries Regenerative Therapies Market Forecast, By Application 11.20.1. Musculoskeletal 11.20.2. Oncology 11.20.3. Wound Care 11.20.4. Dental 11.20.5. Ocular 11.20.6. Other Applications 11.21. CIS countries Regenerative Therapies Market Forecast, By Product 11.21.1. Tissue-engineered Products 11.21.2. Cell Therapies 11.21.3. Gene Therapies 11.21.4. Motor generator 11.21.5. Progenitor & Stem Cell Therapies 11.22. Rest of Europe Regenerative Therapies Market Forecast, By Application 11.22.1. Musculoskeletal 11.22.2. Oncology 11.22.3. Wound Care 11.22.4. Dental 11.22.5. Ocular 11.22.6. Other Applications 11.23. Rest of Europe Regenerative Therapies Market Forecast, By Product 11.23.1. Tissue-engineered Products 11.23.2. Cell Therapies 11.23.3. Gene Therapies 11.23.4. Progenitor & Stem Cell Therapies 11.24. Europe Regenerative Therapies Market Attractiveness Analysis 11.24.1. By Product 11.24.2. By Application 11.25. PEST Analysis 11.26. Key Trends 11.27. Key Developments 12. Asia Pacific Regenerative Therapies Market Analysis 12.1. Key Findings 12.2. Asia Pacific Regenerative Therapies Market Overview 12.3. Asia Pacific Regenerative Therapies Market Value Share Analysis, By Application 12.4. Asia Pacific Regenerative Therapies Market Forecast, By Application 12.4.1. Musculoskeletal 12.4.2. Oncology 12.4.3. Wound Care 12.4.4. Dental 12.4.5. Ocular 12.4.6. Other Applications 12.5. Asia Pacific Regenerative Therapies Market Value Share Analysis, By Application 12.6. Asia Pacific Regenerative Therapies Market Forecast, By Product 12.6.1. Tissue-engineered Products 12.6.2. Cell Therapies 12.6.3. Gene Therapies 12.6.4. Motor generator 12.6.5. Progenitor & Stem Cell Therapies 12.7. Asia Pacific Regenerative Therapies Market Value Share Analysis, by Country 12.8. Asia Pacific Regenerative Therapies Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific Regenerative Therapies Market Analysis, by Country 12.10. China Regenerative Therapies Market Forecast, By Application 12.10.1. Musculoskeletal 12.10.2. Oncology 12.10.3. Wound Care 12.10.4. Dental 12.10.5. Ocular 12.10.6. Other Applications 12.11. China Regenerative Therapies Market Forecast, By Product 12.11.1. Tissue-engineered Products 12.11.2. Cell Therapies 12.11.3. Gene Therapies 12.11.4. Motor generator 12.11.5. Progenitor & Stem Cell Therapies 12.12. India Regenerative Therapies Market Forecast, By Application 12.12.1. Musculoskeletal 12.12.2. Oncology 12.12.3. Wound Care 12.12.4. Dental 12.12.5. Ocular 12.12.6. Other Applications 12.13. India Regenerative Therapies Market Forecast, By Product 12.13.1. Tissue-engineered Products 12.13.2. Cell Therapies 12.13.3. Gene Therapies 12.13.4. Motor generator 12.13.5. Progenitor & Stem Cell Therapies 12.14. Japan Regenerative Therapies Market Forecast, By Application 12.14.1. Musculoskeletal 12.14.2. Oncology 12.14.3. Wound Care 12.14.4. Dental 12.14.5. Ocular 12.14.6. Other Applications 12.15. Japan Regenerative Therapies Market Forecast, By Product 12.15.1. Tissue-engineered Products 12.15.2. Cell Therapies 12.15.3. Gene Therapies 12.15.4. Motor generator 12.15.5. Progenitor & Stem Cell Therapies 12.16. South Korea Regenerative Therapies Market Forecast, By Application 12.16.1. Musculoskeletal 12.16.2. Oncology 12.16.3. Wound Care 12.16.4. Dental 12.16.5. Ocular 12.16.6. Other Applications 12.17. South Korea Regenerative Therapies Market Forecast, By Product 12.17.1. Tissue-engineered Products 12.17.2. Cell Therapies 12.17.3. Gene Therapies 12.17.4. Motor generator 12.17.5. Progenitor & Stem Cell Therapies 12.18. Australia Regenerative Therapies Market Forecast, By Application 12.18.1. Musculoskeletal 12.18.2. Oncology 12.18.3. Wound Care 12.18.4. Dental 12.18.5. Ocular 12.18.6. Other Applications 12.19. Australia Regenerative Therapies Market Forecast, By Product 12.19.1. Tissue-engineered Products 12.19.2. Cell Therapies 12.19.3. Gene Therapies 12.19.4. Motor generator 12.19.5. Progenitor & Stem Cell Therapies 12.20. ASEAN Regenerative Therapies Market Forecast, By Application 12.20.1. Musculoskeletal 12.20.2. Oncology 12.20.3. Wound Care 12.20.4. Dental 12.20.5. Ocular 12.20.6. Other Applications 12.21. ASEAN Regenerative Therapies Market Forecast, By Product 12.21.1. Tissue-engineered Products 12.21.2. Cell Therapies 12.21.3. Gene Therapies 12.21.4. Motor generator 12.21.5. Progenitor & Stem Cell Therapies 12.22. Rest of Asia Pacific Regenerative Therapies Market Forecast, By Application 12.22.1. Musculoskeletal 12.22.2. Oncology 12.22.3. Wound Care 12.22.4. Dental 12.22.5. Ocular 12.22.6. Other Applications 12.23. Rest of Asia Pacific Regenerative Therapies Market Forecast, By Product 12.23.1. Tissue-engineered Products 12.23.2. Cell Therapies 12.23.3. Gene Therapies 12.23.4. Motor generator 12.23.5. Progenitor & Stem Cell Therapies 12.24. Asia Pacific Regenerative Therapies Market Attractiveness Analysis 12.24.1. By Application 12.24.2. By Product 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa Regenerative Therapies Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Regenerative Therapies Market Overview 13.3. Middle East & Africa Regenerative Therapies Market Value Share Analysis, By Application 13.4. Middle East & Africa Regenerative Therapies Market Forecast, By Application 13.4.1. Musculoskeletal 13.4.2. Oncology 13.4.3. Wound Care 13.4.4. Dental 13.4.5. Ocular 13.4.6. Other Applications 13.5. Middle East & Africa Regenerative Therapies Market Forecast, By Product 13.5.1. Tissue-engineered Products 13.5.2. Cell Therapies 13.5.3. Gene Therapies 13.5.4. Motor generator 13.5.5. Progenitor & Stem Cell Therapies 13.6. Middle East & Africa Regenerative Therapies Market Value Share Analysis, by Country 13.7. Middle East & Africa Regenerative Therapies Market Forecast, by Country 13.7.1. GCC Countries 13.7.2. South Africa 13.7.3. Nigeria 13.7.4. Egypt 13.7.5. Rest of Middle East & Africa 13.8. Middle East & Africa Regenerative Therapies Market Analysis, by Country 13.9. GCC Countries Regenerative Therapies Market Forecast, By Application 13.9.1. Musculoskeletal 13.9.2. Oncology 13.9.3. Wound Care 13.9.4. Dental 13.9.5. Ocular 13.9.6. Other Applications 13.10. GCC Countries Regenerative Therapies Market Forecast, By Product 13.10.1. Tissue-engineered Products 13.10.2. Cell Therapies 13.10.3. Gene Therapies 13.10.4. Motor generator 13.10.5. Progenitor & Stem Cell Therapies 13.11. South Africa Regenerative Therapies Market Forecast, By Application 13.11.1. Musculoskeletal 13.11.2. Oncology 13.11.3. Wound Care 13.11.4. Dental 13.11.5. Ocular 13.11.6. Other Applications 13.12. South Africa Regenerative Therapies Market Forecast, By Product 13.12.1. Tissue-engineered Products 13.12.2. Cell Therapies 13.12.3. Gene Therapies 13.12.4. Motor generator 13.12.5. Progenitor & Stem Cell Therapies 13.13. Nigeria Regenerative Therapies Market Forecast, By Application 13.13.1. Musculoskeletal 13.13.2. Oncology 13.13.3. Wound Care 13.13.4. Dental 13.13.5. Ocular 13.13.6. Other Applications 13.14. Nigeria Regenerative Therapies Market Forecast, By Product 13.14.1. Tissue-engineered Products 13.14.2. Cell Therapies 13.14.3. Gene Therapies 13.14.4. Motor generator 13.14.5. Progenitor & Stem Cell Therapies 13.15. Egypt Regenerative Therapies Market Forecast, By Application 13.15.1. Musculoskeletal 13.15.2. Oncology 13.15.3. Wound Care 13.15.4. Dental 13.15.5. Ocular 13.15.6. Other Applications 13.16. Egypt Regenerative Therapies Market Forecast, By Product 13.16.1. Tissue-engineered Products 13.16.2. Cell Therapies 13.16.3. Gene Therapies 13.16.4. Motor generator 13.16.5. Progenitor & Stem Cell Therapies 13.17. Rest of Middle East & Africa Regenerative Therapies Market Forecast, By Application 13.17.1. Musculoskeletal 13.17.2. Oncology 13.17.3. Wound Care 13.17.4. Dental 13.17.5. Ocular 13.17.6. Other Applications 13.18. Rest of Middle East & Africa Regenerative Therapies Market Forecast, By Product 13.18.1. Tissue-engineered Products 13.18.2. Cell Therapies 13.18.3. Gene Therapies 13.18.4. Progenitor & Stem Cell Therapies 13.19. Middle East & Africa Regenerative Therapies Market Attractiveness Analysis 13.19.1. By Application 13.19.2. By Product 13.20. PEST Analysis 13.21. Key Trends 13.22. Key Developments 14. South America Regenerative Therapies Market Analysis 14.1. Key Findings 14.2. South America Regenerative Therapies Market Overview 14.3. South America Regenerative Therapies Market Value Share Analysis, By Application 14.4. South America Regenerative Therapies Market Forecast, By Application 14.4.1. Musculoskeletal 14.4.2. Oncology 14.4.3. Wound Care 14.4.4. Dental 14.4.5. Ocular 14.4.6. Other Applications 14.5. South America Regenerative Therapies Market Forecast, By Product 14.5.1. Tissue-engineered Products 14.5.2. Cell Therapies 14.5.3. Gene Therapies 14.5.4. Progenitor & Stem Cell Therapies 14.6. South America Regenerative Therapies Market Value Share Analysis, by Country 14.7. South America Regenerative Therapies Market Forecast, by Country 14.7.1. Brazil 14.7.2. Colombia 14.7.3. Argentina 14.7.4. Rest of South America 14.8. South America Regenerative Therapies Market Analysis, by Country 14.9. Brazil Regenerative Therapies Market Forecast, By Application 14.9.1. Musculoskeletal 14.9.2. Oncology 14.9.3. Wound Care 14.9.4. Dental 14.9.5. Ocular 14.9.6. Other Applications 14.10. Brazil Regenerative Therapies Market Forecast, By Product 14.10.1. Tissue-engineered Products 14.10.2. Cell Therapies 14.10.3. Gene Therapies 14.10.4. Progenitor & Stem Cell Therapies 14.11. Colombia Regenerative Therapies Market Forecast, By Application 14.11.1. Musculoskeletal 14.11.2. Oncology 14.11.3. Wound Care 14.11.4. Dental 14.11.5. Ocular 14.11.6. Other Applications 14.12. Colombia Regenerative Therapies Market Forecast, By Product 14.12.1. Tissue-engineered Products 14.12.2. Cell Therapies 14.12.3. Gene Therapies 14.12.4. Progenitor & Stem Cell Therapies 14.13. Argentina Regenerative Therapies Market Forecast, By Application 14.13.1. Musculoskeletal 14.13.2. Oncology 14.13.3. Wound Care 14.13.4. Dental 14.13.5. Ocular 14.13.6. Other Applications 14.14. Argentina Regenerative Therapies Market Forecast, By Product 14.14.1. Tissue-engineered Products 14.14.2. Cell Therapies 14.14.3. Gene Therapies 14.14.4. Progenitor & Stem Cell Therapies 14.15. Rest of South America Regenerative Therapies Market Forecast, By Application 14.15.1. Musculoskeletal 14.15.2. Oncology 14.15.3. Wound Care 14.15.4. Dental 14.15.5. Ocular 14.15.6. Other Applications 14.16. Rest of South America Regenerative Therapies Market Forecast, By Product 14.16.1. Tissue-engineered Products 14.16.2. Cell Therapies 14.16.3. Gene Therapies 14.16.4. Progenitor & Stem Cell Therapies 14.17. South America Regenerative Therapies Market Attractiveness Analysis 14.17.1. By Application 14.17.2. By Product 14.18. PEST Analysis 14.19. Key Trends 14.20. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Acelity L.P. Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Mesoblast Ltd. 15.3.3. Nuo Therapeutics, Inc. (Cytomedix). 15.3.4. Astellas Pharma US, Inc. 15.3.5. Organovo Holdings Inc. 15.3.6. Orgenesis Inc. 15.3.7. Sanofi. 15.3.8. Athersys, Inc. 15.3.9. Shire Pharmaceuticals Limited. 15.3.10. Cytori Therapeutics Inc. 15.3.11. Other 16. Primary Key Insights

About This Report

Report ID83993
Category Healthcare
Published DateFebruary 2021
Updated Date
Contact Us